Quantifying the benefits of improved operations for polio outbreak response: A model-based analysis. [PDF]
Sun Y +3 more
europepmc +1 more source
Response to a vaccine-derived poliovirus type 1 event - Sichuan, China, 2024. [PDF]
Yang Q +8 more
europepmc +1 more source
Coverage and associated factors of inactivated polio vaccine uptake among children aged 12-23 months in Sub-Saharan Africa. [PDF]
Wondie WT +9 more
europepmc +1 more source
Safety and Immunogenicity of a Sabin Strain-Based Inactivated Polio Vaccine: A Phase III, Randomized, Blinded, Positive-Control Clinical Trial in Infants Aged Two Months. [PDF]
Zhang H +9 more
europepmc +1 more source
Am80-lipid nanoparticles serve as an enteric mucosal adjuvant following parenteral immunization with inactivated polio vaccine. [PDF]
Eshaghi B +24 more
europepmc +1 more source
Estimating population immunity against serotype-two poliomyelitis from the inactivated polio vaccine in routine immunization across 112 countries: A modelling study. [PDF]
Gray EJ +6 more
europepmc +1 more source
Absorbing the shock: the role of lower-level health facilities in immunization resilience in Sidama, Ethiopia during COVID-19 pandemic. [PDF]
Gedefaw A +10 more
europepmc +1 more source
Factors Associated with Antibiotic Initiation After DaBT-Hib-IPV Vaccination in NICU-Hospitalized Preterm Infants: The Role of C-Reactive Protein. [PDF]
Şimşek H +4 more
europepmc +1 more source
Vaccination in immunocompetent and immunosuppressed youth with special health care needs during healthcare transition. [PDF]
Yarshell FC +9 more
europepmc +1 more source
Unraveling the Mucosal Immunity of Inactivated Poliovirus Vaccine [PDF]
openaire +2 more sources

